SCHEMBL11322337

SCHEMBL11322337

CO[C@@H]1O[C@H](CO)[C@@H](OC(C)=O)[C@H](OC(C)=O)[C@H]1NC(=O)OCc1ccccc1

nearest known ligand 0.54

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 3/20 0.54
▸ LGALS8 O00214 2/20 0.54
▸ KMT2A Q03164 1/20 0.52
▸ POLB P06746 2/20 0.46
▸ MMP9 P14780 1/20 0.45
▸ MMP12 P39900 1/20 0.45
▸ LGALS3 P17931 2/20 0.41
▸ CPB1 P15086 1/20 0.41
▸ ALDH1A1 P00352 2/20 0.41
▸ CYP2D6 P10635 1/20 0.41
▸ MAPK1 P28482 1/20 0.41
▸ CTSB P07858 2/20 0.40
▸ CTSS P25774 2/20 0.40
▸ CTSK P43235 2/20 0.40
▸ CTSL P07711 1/20 0.40
▸ LGALS9 O00182 1/20 0.40
▸ LGALS7; LGALS7B P47929 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11325557 1.00 LMNA (0.54) LMNALGALS8KMT2APOLBMMP9
SCHEMBL11322341 0.91 LMNA (0.58) LMNALGALS8KMT2APOLBMMP9
SCHEMBL11338877 0.87 LMNA (0.48) LMNALGALS8KMT2APOLBCPB1
SCHEMBL11338875 0.87 LMNA (0.48) LMNALGALS8KMT2APOLBCPB1
SCHEMBL8712020 0.86 LMNA (0.53) LMNALGALS8KMT2APOLBMMP9
SCHEMBL12501263 0.85 LGALS8 (0.64) LGALS8LGALS3CPB1LGALS9LGALS7; LGALS7B
SCHEMBL12501267 0.85 LGALS8 (0.64) LGALS8LGALS3CPB1LGALS9LGALS7; LGALS7B
SCHEMBL2007087 0.84 LMNA (0.76) LMNAKMT2APOLBMMP12ALDH1A1
SCHEMBL2007088 0.84 LMNA (0.76) LMNAKMT2APOLBMMP12ALDH1A1
SCHEMBL12837317 0.84 LMNA (0.76) LMNAKMT2APOLBMMP12ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4251515-A ANTITUMOR AGENTS, TREATMENT OF LEUKEMIA SUAMI T 1981-02-17 — — US disclosed
Send feedback